GE HealthCare Technologies Inc. filed a current report on September 22, 2026, disclosing the appointment of Pascal Desroches as a new member of its Board of Directors, effective January 4, 2027.

Key Highlights

  • New Director: Pascal Desroches was appointed to the GE HealthCare Technologies Inc. Board of Directors, effective January 4, 2027.
  • Committee Assignments: Mr. Desroches will serve on both the Audit Committee and the Talent, Culture, and Compensation Committee, effective January 4, 2027.
  • Director Compensation: Mr. Desroches will receive compensation under the Company's non-employee director program as described in the Definitive Proxy Statement filed March 19, 2026.
  • Indemnification Agreement: The Company will enter into an indemnification agreement with Mr. Desroches, using the form included as Exhibit 10.3 to the Annual Report filed February 4, 2026.
  • No Related-Party Transactions: According to the filing, there are no transactions between Mr. Desroches and the Company reportable under Item 404(a) of Regulation S-K.

GE HealthCare Adds Pascal Desroches to Its Governing Board

GE HealthCare Technologies Inc. (NASDAQ:GEHC), the Chicago-based medical technology company incorporated in Delaware and headquartered at 500 W. Monroe Street, disclosed that its Board of Directors approved the appointment of Pascal Desroches as a director on September 22, 2026. The appointment takes effect January 4, 2027. The filing was signed by Frank R. Jimenez, the Company's General Counsel and Corporate Secretary.

According to the filing, the Board simultaneously assigned Mr. Desroches to two standing committees: the Audit Committee and the Talent, Culture, and Compensation Committee, both also effective January 4, 2027. The Company stated that upon joining, he will be compensated in accordance with its existing non-employee director program, the details of which were set out in the Definitive Proxy Statement on Schedule 14A filed with the SEC on March 19, 2026. The Company also disclosed that it will execute an indemnification agreement with Mr. Desroches, based on the standard form previously filed as Exhibit 10.3 to the Company's Annual Report on Form 10-K submitted on February 4, 2026.

The filing states that "there is no arrangement or understanding between Mr. Desroches and any other person pursuant to which he was selected as a director," and that no transactions exist between Mr. Desroches and the Company that would require disclosure under Item 404(a) of Regulation S-K. A press release announcing the appointment was furnished as Exhibit 99 to the filing and is noted as not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

What Was Disclosed

GE HealthCare Technologies Inc. reported the Board-level appointment of Pascal Desroches as a director and member of two committees, effective January 4, 2027, along with the planned execution of a standard indemnification agreement and application of the existing non-employee director compensation program.